CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock

NCT07461961 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cardiogenic Shock
Heart Failure
Inflammation

Interventions

DRUG: Methylprednisone
OTHER: Standard of Care (SOC)

Sponsor

Brigham and Women's Hospital